BioIncept, LLC
Regenerative medicine therapeutics for tissue regeneration and cellular repair
- Sector
- Biotech
- Headquarters
- Cherry Hill, NJ
- Latest Form D
- $3.1M, Oct 2020
- Total capital
- $9.6M
- Federal grants
- $2.6M
- 6 awards · 2015–2025
- Rank in peer group#402 of 514
- Private capital raised
- $7M
- 4 Form D · last Oct 2020
- 72 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 34 pending · first 2018
- Rank in peer group#58 of 514
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury$817K
- Federal grantHealth and Human S · Phase II · Synthetic PreImplantation Factor (sPIF) plus hypothermia to treat neonatal brain injury$831K
- Private capital raisedForm D · SEC · 4th filing$3.1M
- Federal grantHealth and Human S · Phase I · PreImplantation Factor plus hypothermia to treat neonatal brain injury$225K
- Federal grantHealth and Human S · Phase I · Development of a novel therapy for mitigation of the irradiation-inducedgastrointestinal syndrome$207K
- Private capital raisedForm D · SEC · 3rd filing$2M
- Offering registeredForm D · SEC · 2nd filing$13.5M
- Private capital raisedForm D · SEC · 1st filing$1.8M
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase I · PreImplantation Factor plus hypothermia to treat neonatal brain injury$223K
- Federal grantHealth and Human S · Phase I · Treatment of Acute Radiation Syndrome using PIF, a Natural Immune Modulator$298K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#58 · top 11%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Eytan R. BarneaResearcherExecutive Officer, DirectorLinked by $207K in grants as PI
- Barton W. O'BrienDirectorNamed in SEC Form D filings
- Brian H FosterExecutive OfficerNamed in SEC Form D filings
- David R DuncanDirectorNamed in SEC Form D filings
- Dennis W. SpinkDirectorNamed in SEC Form D filings
- George W. FrankDirectorNamed in SEC Form D filings
Show all 9 people
- George W Frank, Jr.DirectorNamed in SEC Form D filings
- Jacqueline H. BarneaExecutive Officer, DirectorNamed in SEC Form D filings
- Julia W. CorelliDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 40- PendingCompositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als) And Related DisordersUSPTOApplication 18834179
- PendingSystems, Compositions And Methods Of Determining Viability Of Embryos Using The SameUSPTOApplication 18032128
- PendingMethods Of Treating Nash And Compositions ThereforeUSPTOApplication 16975375
Show all 40 patent records
- Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als) And Related DisordersMay 29, 2025 · Application 18834179Pending
- Systems, Compositions And Methods Of Determining Viability Of Embryos Using The SameDec 14, 2023 · Application 18032128Pending
- Methods Of Treating Nash And Compositions ThereforeJun 22, 2023 · Application 16975375Pending
- Peptides And Methods Of Transplantation And Restorative Organ FunctionAug 11, 2022 · Application 17513607Pending
- Mutant Peptides And Methods Of Treating Subjects Using The SameAug 24, 2021 · US 11,096,987Granted
- Compositions And Methods For The Treatment Of NeurodamageAug 17, 2021 · US 11,090,355Granted
- Compositions And Methods For Modulating The Immune SystemMay 11, 2021 · US 11,000,566Granted
- Compositions And Methods For Treatment Of Intracellular Damage And Bacterial InfectionMar 23, 2021 · US 10,953,071Granted
- Pif-transfected Cells And Methods Of UseNov 12, 2020 · Application 16656497Pending
- Compositions And Methods For Modulating The Immune SystemOct 20, 2020 · US 10,806,771Granted
- Peptides And Methods Of Transplantation And Restorative Organ FunctionAug 6, 2020 · Application 16632073Pending
- Peptides And Methods Of Treating Endometriosis Using The SameNov 8, 2018 · Application 15773385Pending
- Compositions And Methods For Modulating The Immune SystemSep 11, 2018 · US 10,071,131Granted
- Pif Binding As A Marker For Immune DysregulationNov 23, 2017 · Application 15524249Pending
- Compositions And Methods For Treating Acute Radiation SyndromeNov 9, 2017 · Application 15512001Pending
- Pif-transfected Cells And Methods Of UseSep 15, 2016 · Application 15031671Pending
- Methods Of Treating Nash And Compositions ThereforeApplication 62634189Pending
- Peptides And Methods Of Treating Dystrophy-related Disorders Using The SameApplication PCTUS2018019279Pending
- Peptides And Methods Of Transplantation And Restorative Organ FunctionApplication 62533636Pending
- Peptides And Methods Of Transplantation And Restorative Organ FunctionApplication PCTUS2018042565Pending
- Methods Of Treating Nash And Compositions ThereforeApplication PCTUS2019019256Pending
- Peptides And Methods Of Treating Dystrophy-related Disorders Using The SameApplication 62462292Pending
- Systems, Compositions And Methods Of Determining Viability Of Embryos Using The SameApplication 63092483Pending
- Peptides And Methods Of Treating Endometriosis Using The SameApplication PCTUS2016060319Pending
- Compositions And Methods For The Treatment Of NeurodamageApplication PCTUS2016048601Pending
- Systems, Compositions And Methods Of Determining Viability Of Embryos Using The SameApplication PCTUS2021055071Pending
- Peptides And Methods Of Treating Endometriosis Using The SameApplication 62317628Pending
- Mutant Peptides And Methods Of Treating Subjects Using The SameApplication PCTUS2016022725Pending
- Pif Binding As A Marker For Immune DysregulationApplication PCTUS2015058877Pending
- Compositions And Methods For Treating Acute Radiation SyndromeApplication PCTUS2015050532Pending
- Compositions And Methods Of Treating Amyotrophic Lateral Sclerosis (als) And Related DisordersApplication 63268670Pending
- Pif Binding As A Marker For Immune DysregulationApplication 62113298Pending
- Pif Binding As A Marker For Immune DysregulationApplication 62074384Pending
- Pif-transfected Cells And Methods Of UseApplication PCTUS2014061814Pending
- Methods For Treating Acute Radiation SyndromeApplication 62051077Pending
- PIF-Transfected Cells and Methods of UseApplication 61895088Pending
- Compositions And Methods For Treatment Of Intracellular DamageApplication PCTUS2012027480Pending
- Compositions And Methods For Modulating The Immune SystemApplication PCTUS2007068321Pending
- Pif TetrapeptidesApplication PCTUS2006014969Pending
- Antiproliferative Peptides And Antibodies For Their DetectionApplication PCTUS2005025140Pending
Related companies, and why
- KallyopeSimilar federal contract value in Biotech · null in contracts
- Ashvattha Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- PALATIN TECHNOLOGIES INCSimilar federal contract value in Biotech · null in contracts
- Diceros Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- BIOPHY, INC.Similar federal contract value in Biotech · null in contracts
- Deciduous TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .